Enhancer hijacking activates GFI1 family oncogenes in medulloblastomaPaul A. Northcott, Jaroslav Štěrba, Scott Zuyderduyn et al.|Nature|2014Cited by 674
Lsd1 as a therapeutic target in Gfi1-activated medulloblastomaCatherine Lee, Robert J. Wechsler‐Reya, Vasilisa A. Rudneva et al.|Nature Communications|2019Cited by 84
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A. Herbst, Sascha Dietrich, Mattias Vesterlund et al.|Nature Communications|2022Cited by 42
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy targetLaura Llaó Cid, Martina Seiffert, Jkl Wong et al.|Nature Communications|2025Cited by 14
High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy targetLaura Llaó Cid, Martina Seiffert, JKL Wong et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 6